Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
W Tian, Y Deng, L Li, H He… - … Journal of Oncology, 2013 - spandidos-publications.com
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
[PDF][PDF] Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
WEI TIAN, Y DENG, L LI, H HE… - INTERNATIONAL …, 2013 - scholar.archive.org
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
WEI TIAN, Y DENG, L LI, H HE… - INTERNATIONAL …, 2013 - ingentaconnect.com
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death.
W Tian, Y Deng, L Li, H He, J Sun… - International Journal of …, 2012 - europepmc.org
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
W Tian, Y Deng, L Li, H He… - … Journal of Oncology, 2013 - spandidos-publications.com
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
WEI TIAN, Y DENG, L LI, H HE… - International Journal of …, 2013 - search.proquest.com
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
[PDF][PDF] Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
WEI TIAN, Y DENG, L LI, H HE, JIE SUN… - INTERNATIONAL …, 2013 - researchgate.net
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
W Tian, Y Deng, L Li, H He… - International journal of …, 2013 - pubmed.ncbi.nlm.nih.gov
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
[PDF][PDF] Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death
WEI TIAN, Y DENG, L LI, H HE… - INTERNATIONAL …, 2013 - scholar.archive.org
Multidrug resistance (MDR) is a major challenge in cancer therapy. Apoptosis tolerance is
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …
one of the key mechanisms of MDR. Honokiol, a small-molecule pharmacologically active …